Case Analysis and Defining the Framework of Pharmaceutical Companies: How CSR affects the performance in the Pharmaceutical industry

Preferred lаnguаge style: Englіsh (U.S.) <br /><br />Comments on document which will be uploaded, please change the document according to the following comments by my
professor:<br /><br />”Although the research objectives have been modified (p.8), the introduction of the document still refers to the relationship between CSR and
business profitability it has to be eliminated.<br />Section 2.6 (pp.20-22) also discusses the relationship between CSR and sales which needs to be changed.<br /><br
/>The research objectives were modified in accordance with the previous comments. <br /><br />Section 2.4 (pp.16-17) entitled “CSR activities in pharmaceutical
companies” should not appear in the literature review chapter. <br /><br />The literature review should focus on a review of academic literature focusing on the
research objectives: <br />(i) CSR actions; (ii) communication of CSR’s efforts; (iii) business incentives to engage in CSR actions. <br />A REORGANIZATION OF THE
CHAPTER OF LITERATURE REVIEW IS THEREFORE NECESSARY. <br /><br />Thus, the title of Section 2 (pp.13-22) should not refer to the pharmaceutical industry. <br /><br
/>The methodology was modified to make it compatible with the research objectives. However, section 2.2 (pp.25-26) should be eliminated because interviews conducted by
other researchers are secondary data for your study. <br /><br />Considering the following comment: The methodology based on an econometric model as proposed does not
hold the road: A sample of 5 firms is clearly insufficient to have statistically valid results: Access to the data needed to estimate the proposed model seems
problematic. How do I get an estimate of dollar expenditures for each CSR category of CSR action? I do not think that the sources of information mentioned in the text
(corporate websites, financial reports) contain this level of detail.”